Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

AL, Whone; RL, Watts; AJ, Stoessl; M, Davis; S, Reske; C, Nahmias; AE, Lang; O, Rascol; MJ, Ribeiro; P, Remy; WH, Poewe; RA, Hauser; DJ, Brooks

doi:10.1002/ana.10609

Public

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

Shared by NobleBlocks on Jul 1, 2003 • 12:00 AM UTC

Authors:

Whone AL

Watts RL

Stoessl AJ

Abstract

Preclinical studies suggest ropinirole (a D2/D3 dopamine agonist) may be neuroprotective in Parkinson's disease (PD), and a pilot clinical study using (18)F-dopa positron emission tomography (PET) suggested a slower loss of striatal dopamine storage with ropinirole compared with levodopa. This prosp...

Discussions